Influence of different calcic antagonists on the Caco-2 cell monolayer integrity or "TEER, a measurement of toxicity?"

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 30, Issue 1-2, 2005, Pages 85-90

  Mathieu, F ^a   Galmier, M J ^a,b   Pognat, J F ^a   Lartigue, C ^a  

^a INSERM   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Caco 2; Calcic antagonists; TEER; Toxicity

Indexed keywords

BEPRIDIL; CALCIUM ANTAGONIST; DILTIAZEM; PERHEXILINE; PRENYLAMINE; VERAPAMIL;

ARTICLE; CELL STRAIN CACO 2; COMPARATIVE TOXICOLOGY; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; ION CURRENT; MEMBRANE PERMEABILITY; MONOLAYER CULTURE; TRANSEPITHELIAL ELECTRICAL RESISTANCE;

EID: 21344431883     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03226412     Document Type: Article

References (22)

1. Oliver GJA, Pemberton MA, Rhodes C. (1986): An in vitro corrosivity test - modifications and validation. Food Chem. Toxic, 24, 507-512.
2. Shasby DM, Hampton F. (1989): Effects of chlorinated amines on endothelial and epithelial barriers in vitro and ex vivo. Exp. Lung. Res., 15, 345-357.
3. Atisook K, Madara JL. (1991): An oligopeptide permeates intestinal tight junctions at glucose-elicited dilatations. Gastroenterology, 100, 719-724.
4. Sakai M, Noach ABJ, Blom-Roosemalen MCM, De Boer AG, Breimer DD. (1994): Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers. Biochem. Pharmacol., 48 (6), 1199-1210.
5. Pasternak, AS, Miller, WM. (1996): Measurement of trans-epithelial electrical resistance in perfusion: potential application for in vitro ocular toxicity testing. Biotechnol. Bioeng., 50, 568-579.
6. Twiss IM, De Water R, Den Hartigh J, et al. (1994): Cytotoxic effetcs of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport. J. Pharm. Sci., 83(5), 699-703.
7. Welsh MJ, Shasby DM, Husted RM. (1985): Oxidants increase paracellular permeability in a cultured epithelial cell line. J. Clin. Invest., 76, 1155-1168.
8. Werner U, Kissel T, Reers M. (1996): Effects of permeation enhancers on transport of a peptidomimetic Thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2). Pharm. Res., 13 (8), 1219-1227.
9. Janecki A, Jakubowiak A, Steinberger A. (1991): Regulation of transepithelial electrical resistance in two compartment Sertoli cell cultures: in vitro model of the blood-testis barrier. Endocrinol., 129, 1489-1496.
10. Cheek JM, KIM K-J, Crandall ED. (1989): Tight monolayers of rat alveolar epithelial cells: bioelectric properties and active sodium transport. Am. J. Physiol., 256, C688-C693.
11. Artursson P and Magnusson C. (1990): Epithelial transport of drugs in cell culture. II: effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J. Pharm. Sci., 79 (7), 595-600.
12. Bailey CA, Bryla P, Waseem Malick A. (1996): The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development. Adv. Drug Deliver Rev., 22, 85-103.
13. Parisi M, Escobar E, Huet C, Ripoche P, Louvard D, Bourguet J. (1993): Water handling in Caco-2 cells: effects of acidification of the medium. Pflüg Arch. Eur. J. Phy., 423, 1-6.
14. Velarde G, Ait-Aissa S, Gillet C, Rogerieux F, Lambre C, Vindimian E, Porcher JM. (1999): Use of Transepithelial Electrical Resistance in the study of pentachlorophenol toxicity. Toxicology in Vitro, 13, 723-727.
15. Okada T, Narai A, Matsunaga S, Fusetani N, Shimizu M. (2000): Assessment of the marine toxins by monitoring the integrity of human intestinal Caco-2 cell monolayers. Toxicology in Vitro, 14, 219-226.
16. Stenson WF, Easom RA, Riehl TE, Turk J. (1993): Regulation of paracellular permeability in Caco-2 cell monolayers by protein kinase C. Am. J. Physiol., 265, G955-G962.
17. Madara JL. (1983): Increases in Guinea pig small intestinal transepithelial resistance induced by osmotic loads are accompanied by rapid alterations in absorptive-cell tight-junction structure. J. Cell Biol., 97, 125-136.
18. Stenson W, Preston AS, Johson JP and Handler JS (1993): Regulation of paracellular permeability in Caco-2 cell monolayers by protein kinase C. Am. J. Physiol., 265, G955-G962.
19. Mathieu F, Galmier M-J, Pognat J-F, Petit J, Lartigue C. (1999): Transepithelial transport of bepridil in the human cell line, Caco-2, using two media DMEMc and HBSS. Int. J. Pharm., 181, 203-217.
20. Mathieu F, Galmier M-J, NICOLAY A, Pognat J-F, Petit J, Lartigue C. (2003): Transepithelial transport of bepridil in the human cell line, Caco-2, using a "dynamic model". Eur. J. Drug Metab. Pharmacokinet., 28 (2), 155-160.
21. Damatte E, Galmier MJ, Lartigue-Mattei C, Pognat JF, Busch N, Chabard JL. (1996): Comparative study of the biotransformation of bepridil analogs in isolated liver cells from one rat. Relationships between structure and in vitro liver toxicity. Eur. J. Drug Metab. Pharmacokinet., 21(4), 315-325
22. Gan L-S, Yanni S, Thakker D. (1998): Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonists. Pharm. Res., 15(1), 53-57.